Healthcare providers are looking to medical devices to play a new role in hospital care, providing a whole-patient view of health through technologies that talk to each other and help clinicians make decisions about treatment.
MassDevice Q&A
Patient safety: Q&A with Masimo founder Joe Kiani
Zoll CEO Packer on device tax repeal efforts: No pessimists on the front lines
As the medical device excise tax creeps closer to its planned launch date, all eyes are on Congress to see whether medtech lobbying efforts will yield a win for the industry.
While lawmakers weigh the tax and argue their way toward the so-called fiscal cliff, device industry stakeholders are placing their bets on whether or not the excise tax will survive until January.
Strathspey Crown and the first Medicare-Medicaid opt-out company in medtech | A conversation with Robert Grant
If Robert Grant is successful – a good bet, judging by his track record – 1 day his new venture, private equity firm Strathspey Crown, will be known as a leader in the nascent field of "lifestyle medicine."
Invisalign trailblazes a path direct to the consumer| A conversation with Align Technology CEO Tom Prescott
Crooked-toothed teens may want to consider sliding a picture of Tom Prescott next to that fading "Twilight" poster on the wall.
Sanovas seeks $25 million as it gears up to go commercial
Most startup medical device companies raise 10s of millions to research and develop their products before they even get to the commercial stage. But for Sanovas and co-founder Larry Gerrans, the 12-year journey to that point required a scant $9 million – all raised from the pulmonary device firm’s founders, friends and family, Gerrans told MassDevice.com last month.
OmniGuide saddles up for some scale
MassDevice.com first visited OmniGuide in 2009, when the Cambridge, Mass.-based medical device company was developing the BeamPath laser scalpel, aiming for 2 orders of magnitude more precision than the most precise soft-tissue cutting tool.
Today the company has refined that technology even further and has turned its focus toward ramping up commercialization of the BeamPath device, CEO Scott Flora told us this month.
Diabetes: Europe, the U.S. and the medtech pendulum’s swing
GlySure CEO Christopher Jones has a career spanning more than 2 decades and 2 continents, during which he’s seen the medtech regulatory pendulum swing from the Europe to the U.S. and back.
In an exclusive interview with MassDevice.com, Jones told us about being an American executive in the U.K., changing regulatory timelines and challenges to look for with a Europe-1st strategy.
MassDevice: You have a career that has spanned work with regulators in the U.S. and abroad. Tell us about your background.
The weight loss pacemaker: MassDevice Q&A with EnteroMedics
EnteroMedics (NSDQ:ETRM) is looking to control metabolic disease by attacking the problem closer to its source – human behavior.
Battle in Silicon Valley: Device makers trade barbs in the fight to gain share in robot assisted procedures
USC cardiology chief Saxon: ‘People are using their phones for everything except their own health. We aim to change that.’
As cardiology chief of the Keck School of Medicine at the University of Southern California, Dr. Leslie Saxon is spearheading a successful mobile health innovation center called the Center for Body Computing. Founded in 2010, the coalition works with engineers, device companies and thought leaders to develop mobile health software and apps.